Équipe Sonaro

Au service d’une innovation de pointe

Karina Gasbarrino. Sonaro

Dr. Karina Gasbarrino, PhD

Cofondatrice et PDG
Kashif Khan. Sonaro

Dr. Kashif Khan, MD, PhD

Cofondateur et directeur scientifique
Alex Benjamin. Sonaro

Dr. Alex Benjamin, PhD

Directeur de la technologie
Jose L. Ramirez-Garcialuna. Sonaro

Dr. Jose L. Ramirez-GarciaLuna, MD, PhD

Directeur médical
Dr. Sabir Taj. Sonaro

Dr. Sabir Taj, MD, MS, RPVI

Conseiller principal en imagerie médicale
Étienne Lescarbeault. Sonaro

Étienne Lescarbeault, MEng

Développeur IA et ingénieur en apprentissage automatique
Yehor Sanko. Sonaro

Yehor Sanko, A.A.S.

Développeur full-stack

Histoire de Sonaro

Notre parcours et notre vision

Constitution de Sonaro inc.

February 2023

Constitution de Sonaro inc. officially established with a mission to revolutionize cardiovascular care through advanced diagnostic tools like Vaso3D™.

Dépôt d’une demande de brevet international

April 2024

Sonaro's proprietary technology, Vaso3D™, is protected under an international patent application, paving the way for secure global expansion and commercialization.

Fin de la collecte de données

May 2024

Completion of initial data collection for Vaso3D™, providing a robust dataset to validate and refine the AI algorithms used in detecting vascular diseases.

Étude pilote montréalaise

July 2024

The clinical pilot study commenced, successfully assessing the effectiveness and accuracy of Vaso3D™ in a real-world medical environment. The study gathered valuable feedback that was used to further improve the product. Preliminary data demonstrated a 90% reduction in ultrasound scan time with Vaso3D™.

Réunion préalable à la soumission FDA

January 2025

Successful FDA pre-submission meeting confirms Vaso3D™ falls under the Class II 510(k) pathway, providing regulatory clarity for the commercialization roadmap.

Études de validation clinique aux États-Unis

Launched June 2025

Comprehensive clinical validation studies to further demonstrate Vaso3D™'s efficacy, safety, and clinical benefits for regulatory submission.

Entrée en phase nationale des demandes de brevet

October 2025

Filed in Canada, the U.S., the European Union, Japan, Singapore, and Australia, strengthening Sonaro's international IP protection and technological defensibility.

Moments forts de nos jalons

Karina at SheBoot 2024 Finale
Dr. Karina Gasbarrino pitching at the SheBoot 2024 Finale where Sonaro won the first investment prize
(November 2024)
Sonaro at RSNA 2024
Sonaro showcasing Vaso3D™ at the Radiological Society of North America Annual Meeting
(December 2024)
Équipe Picture 6
McGill Dobson Centre for Entrepreneurship is a steadfast supporter of Sonaro
(October 2023)
Équipe Picture 4
Sonaro's First Full Équipe Retreat in Montreal
(August 2024)
Équipe Picture 2
The Sonaro team among 5 start-ups showcased at the McGill Dobson Centre for Entrepreneurship's Opening Ceremony
(September 2024)
Équipe Picture 1
The Sonaro team at the Quebec Consortium of High-Tech Incubators' Demo Day
(February 2024)
Équipe Picture 5
Sonaro team looking sharp at the Pierre Péladeau Bursaries finals, where Sonaro proudly took home second prize
(April 2023)
Équipe Picture 3
Sonaro's innovative technology presented at the Image Guided Therapeutics Symposium hosted by INOVAIT Canada
(June 2024)